Teon Therapeutics
Teon Therapeutics is a biotech company in Redwood City, United States, founded in 2017. It has raised $30.0M across 1 round, most recently a $30.0M Series A in February 2021.
- Headquarters
- Redwood City
- Employees
- 11–50
- Founded
- 2017
- Website
- teontherapeutics.com
- Total Funding
- $30.0M
- Last Round
- $30.0M Series AFeb 2021
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 2 investors for this company. The full record is or through the API.
About
Teon Therapeutics is a clinical-stage biopharmaceutical company developing once-daily, oral cancer medications designed to restore anti-tumor immunity by targeting untapped metabolic signaling pathways, including G-protein coupled receptor (GPCR) signaling. Only 12% of patients with solid tumors are currently served by immunotherapy drugs available today, and Teon's pipeline aims to reach more of these difficult-to-treat cancer patients with an oral, once-daily treatment option.
Summary
It lists 11–50 employees. It has raised $30.0M in total across 1 round, most recently a $30.0M Series A round in Feb 2021. Investors include Oceanpine Capital and Kaitai Capital.
Funding History
Feb 2021
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/teon-therapeutics"><img src="https://indexed.vc/api/badge/company/teon-therapeutics" alt="Teon Therapeutics on Indexed.vc" width="260" height="76" /></a>